Cancer; inflammation

INDICATION: Colorectal cancer; asthma

Mouse and cell culture studies identified a RIPK2-inhibiting analog of Iclusig ponatinib that could help treat colorectal cancer and asthma.

Read the full 238 word article

User Sign In